Showing results (21-30 of 37) with videos related to

Sort By:
Pageof 4
Experimental Hematology|September 21, 2010
Reduced-intensity conditioning with Fludarabin, oral Busulfan, and thymoglobulin allows long-term disease control and low transplant-related mortality in patients with hematological malignanciesDidier Blaise, Laure Farnault, Catherine Faucher, et al.
Mediterranean Journal of Hematology and Infectious Diseases|May 14, 2013
Impact of pretransplant donor and recipient cytomegalovirus serostatus on outcome for multiple myeloma patients undergoing reduced intensity conditioning allogeneic stem cell transplantationJean El-Cheikh, Raynier Devillier, Roberto Crocchiolo, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 17, 2014
Poor outcome with nonmyeloablative conditioning regimen before cord blood transplantation for patients with high-risk acute myeloid leukemia compared with matched related or unrelated donor transplantationRaynier Devillier, Samia Harbi, Sabine Fürst, et al.
Cancer|February 5, 2015
Unrelated cord blood compared with haploidentical grafts in patients with hematological malignanciesJean El-Cheikh, Roberto Crocchiolo, Sabine Furst, et al.
European Journal of Haematology|March 6, 2012
Comparable outcomes between unrelated and related donors after reduced-intensity conditioning allogeneic hematopoietic stem cell transplantation in patients with high-risk multiple myelomaJean El-Cheikh, Roberto Crocchiolo, Jean-Marie Boher, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|September 6, 2015
Haploidentical T Cell-Replete Transplantation with Post-Transplantation Cyclophosphamide for Patients in or above the Sixth Decade of Age Compared with Allogeneic Hematopoietic Stem Cell Transplantation from an Human Leukocyte Antigen-Matched Related or Unrelated DonorDidier Blaise, Sabine Fürst, Roberto Crocchiolo, et al.
European Journal of Cancer (Oxford, England : 1990)|February 27, 2016
Immunohistochemical subtypes predict survival in metastatic breast cancer receiving high-dose chemotherapy with autologous haematopoietic stem cell transplantationLaurys Boudin, Christian Chabannon, Patrick Sfumato, et al.
Journal of Cancer|November 24, 2016
Prognostic impact of hormone receptor- and HER2-defined subtypes in inflammatory breast cancer treated with high-dose chemotherapy: a retrospective studyLaurys Boudin, Anthony Gonçalves, Patrick Sfumato, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 10, 2013
Antithymocyte globulin in reduced-intensity conditioning regimen allows a high disease-free survival exempt of long-term chronic graft-versus-host diseaseRaynier Devillier, Sabine Fürst, Jean El-Cheikh, et al.
Bulletin Du Cancer|February 19, 2017
[Impact of Her2 and BRCA1/2 status in high-dose chemotherapy and autologous stem cells transplantation in the treatment of breast cancer: The Institut Paoli Calmettes' experience]Laurys Boudin, Christian Chabannon, Patrick Sfumato, et al.
Pageof 4